• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Super Levitra is a pharmaceutical product that combines two active ingredients: vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor, and dapoxetine, a selective serotonin reuptake inhibitor (SSRI). This dual-action medication is designed to address two common male sexual dysfunctions: erectile dysfunction (ED) and premature ejaculation (PE). While Levitra (vardenafil alone) is primarily used for ED, and dapoxetine is used for PE, their combination in Super Levitra offers a convenient single-pill solution for men who experience both conditions simultaneously. This report provides an overview of Super Levitra, including its pharmacology, indications, dosage, efficacy, safety profile, and practical considerations.

Pharmacology and Mechanism of Action

Vardenafil works by inhibiting PDE5, an enzyme that degrades cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. During sexual stimulation, nitric oxide is released, leading to increased cGMP levels, which relaxes smooth muscle and allows blood flow into the penile tissues, resulting in an erection. By blocking PDE5, vardenafil enhances and prolongs this effect, facilitating a firm erection sufficient for sexual activity. Its onset of action is typically within 25–60 minutes, and its effects can last up to 4–5 hours.

Dapoxetine is a short-acting SSRI that increases serotonin activity in the synaptic cleft, thereby delaying the ejaculatory reflex. Unlike chronic SSRIs used for depression, dapoxetine is taken on-demand, usually 1–3 hours before anticipated sexual activity. It has a rapid absorption and elimination half-life of about 1.5 hours, making it suitable for acute use. The combination in Super Levitra allows both drugs to work synergistically: vardenafil addresses the difficulty in achieving or maintaining an erection, while dapoxetine helps control the timing of ejaculation, improving overall sexual satisfaction.

Indications and Target Population

Super Levitra is indicated for men with ED who also suffer from PE. ED is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. PE is characterized by ejaculation that always or nearly always occurs before or within about one minute of vaginal penetration, with a lack of control over ejaculation and causing distress. Studies suggest that ED and PE often coexist; men with ED may develop secondary PE due to anxiety about losing their erection, while those with primary PE may experience ED as a result of performance anxiety. Super Levitra is not intended for women, children, or men without these specific conditions.

Dosage and Administration

Super Levitra is available in a fixed-dose combination tablet, typically containing vardenafil 20 mg and dapoxetine 60 mg, though other strengths exist (e.g., vardenafil 10 mg + dapoxetine 30 mg). The recommended starting dose is one tablet taken approximately 1–3 hours before sexual activity. It should be swallowed whole with water, preferably on an empty stomach to avoid delayed absorption from high-fat meals. The maximum recommended frequency is once per day. Patients over 65 years or those with mild to moderate hepatic impairment may require dose adjustment. Concomitant use with alcohol should be limited, as excessive alcohol can impair erection and increase side effects.

Efficacy

Clinical trials have demonstrated that Super Levitra significantly improves both erectile function and ejaculatory control compared to placebo. In a randomized, double-blind study, men taking the combination reported higher rates of successful intercourse attempts, greater satisfaction with their erections, and longer intravaginal ejaculatory latency times (IELT) than those taking vardenafil alone or placebo. The dual mechanism addresses the interplay between ED and PE, offering a holistic treatment option. However, the efficacy may vary depending on the severity of each condition and the individual's overall health.

Side Effects and Safety Profile

Common side effects include headache, flushing, dizziness, nausea, nasal congestion, and dyspepsia, similar to those of vardenafil alone. Dapoxetine may add side effects such as diarrhea, insomnia, and increased sweating. Serious but rare side effects include priapism (prolonged erection lasting more than 4 hours), sudden hearing loss, and cardiovascular events like myocardial infarction or stroke. Because vardenafil can lower blood pressure, Super Levitra is contraindicated in men taking nitrates (for chest pain) or certain alpha-blockers (for prostate conditions), as this combination can cause severe hypotension. It should not be used in men with severe heart failure, unstable angina, or recent stroke. Dapoxetine is contraindicated in those with moderate to severe hepatic impairment, severe renal impairment, or a history of mania, bipolar disorder, or suicidal thoughts. Men with a history of syncope (fainting) should use caution, as dapoxetine can cause orthostatic hypotension.

Drug Interactions

Super Levitra interacts with a range of medications. Nitrates (e.g., nitroglycerin) are absolutely contraindicated due to the risk of profound hypotension. CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, erythromycin) can increase vardenafil concentrations, requiring dose reduction. Dapoxetine should not be combined with other SSRIs, SNRIs, MAOIs, or thioridazine due to the risk of serotonin syndrome. It also interacts with potent CYP2D6 inhibitors (e.g., paroxetine, fluoxetine) which may increase dapoxetine exposure. Alcohol and recreational drugs that cause sedation should be avoided.

Contraindications

Super Levitra is contraindicated in men with: known hypersensitivity to either component, severe hepatic impairment (Child-Pugh class C), 5mg da €0.56 — Atorvastatin (http://ideaoncanvas.it/) end-stage renal disease (dialysis), uncontrolled hypertension, hypotension (blood pressure <90/50 mmHg), or a history of non-arteritic anterior ischemic optic neuropathy (NAION) related to PDE5 inhibitors. It is also not recommended for men with a predisposition to priapism (e.g., sickle cell anemia, multiple myeloma, leukemia).

Practical Considerations and Counseling

Before prescribing Super Levitra, healthcare providers should conduct a thorough medical history and physical exam to identify underlying causes of ED (e.g., diabetes, vascular disease) and PE (e.g., anxiety, prostatitis). Counseling should include instructions on proper use, potential side effects, and the importance of not exceeding the recommended dose. Patients should be advised that the medication does not protect against sexually transmitted infections and is not a substitute for safe sex practices. Additionally, it is not intended for use in women or children.

Conclusion

Super Levitra offers a valuable treatment option for men with coexisting erectile dysfunction and premature ejaculation. Its dual mechanism of action provides a synergistic benefit, improving both erectile function and ejaculatory control. However, like all medications, it carries risks and is not suitable for everyone. A careful assessment of cardiovascular health and potential drug interactions is essential. Patients should use it under medical supervision and report any adverse effects. With proper use, Super Levitra can enhance sexual quality of life for those who suffer from these common conditions.